Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Morel

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Praxis|December 3, 1996
[Dietary approach to obesity]Y Morel
Presse Medicale (Paris, France : 1983)|May 25, 1991
[Gene heterogeneity in adrenal 21-hydroxylase]Y Morel
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[Biological targets of oxidative stress]R Barouki, Y Morel
The Biochemical Journal|May 5, 2000
The repression of nuclear factor I/CCAAT transcription factor (NFI/CTF) transactivating domain by oxidative stress is mediated by a critical cysteine (Cys-427)Y Morel, R Barouki
La Revue Du Praticien|June 15, 1992
[Androgen receptor. From molecular biology to clinics]Y Morel, F Mebarki
The Journal of Biological Chemistry|October 3, 1998
Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1Y Morel, R Barouki
The Biochemical Journal|September 8, 1999
Repression of gene expression by oxidative stressY Morel, R Barouki
Biochemical Pharmacology|March 10, 2001
Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implicationsR Barouki, Y Morel
Journal De La Societe De Biologie|April 10, 2002
[Oxidative stress and gene expression]R Barouki, Y Morel
Advances in Human Genetics|January 1, 1991
Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyY Morel, W L Miller
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Praxis|December 3, 1996
[Dietary approach to obesity]Y Morel
Presse Medicale (Paris, France : 1983)|May 25, 1991
[Gene heterogeneity in adrenal 21-hydroxylase]Y Morel
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[Biological targets of oxidative stress]R Barouki, Y Morel
The Biochemical Journal|May 5, 2000
The repression of nuclear factor I/CCAAT transcription factor (NFI/CTF) transactivating domain by oxidative stress is mediated by a critical cysteine (Cys-427)Y Morel, R Barouki
La Revue Du Praticien|June 15, 1992
[Androgen receptor. From molecular biology to clinics]Y Morel, F Mebarki
The Journal of Biological Chemistry|October 3, 1998
Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1Y Morel, R Barouki
The Biochemical Journal|September 8, 1999
Repression of gene expression by oxidative stressY Morel, R Barouki
Biochemical Pharmacology|March 10, 2001
Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implicationsR Barouki, Y Morel
Journal De La Societe De Biologie|April 10, 2002
[Oxidative stress and gene expression]R Barouki, Y Morel
Advances in Human Genetics|January 1, 1991
Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyY Morel, W L Miller
Pageof 14